---
figid: PMC9691330__OMCL2022-4661519.003
pmcid: PMC9691330
image_filename: OMCL2022-4661519.003.jpg
figure_link: /pmc/articles/PMC9691330/figure/fig3/
number: Figure 3
figure_title: ''
caption: 'BHF177 targets the GABAB receptor and NR2B NMDA subunit by inhibiting the
  PKC-CaMKII-ERK-CREB pathway in DNP rats. (a) The mRNA expression of GABAB receptors,
  NR2B, PKC, or CaMKII in spinal dorsal horn tissues of DNP rats determined using
  RT-qPCR. (b) The protein expression of GABAB receptors, NR2B, PKC, CaMKII, p-ERK1/2,
  or p-CREB in spinal dorsal horn tissues of DNP rats determined using immunoblotting.
  (c) Immunohistochemistry of the number of cells positive for related markers in
  rat spinal dorsal horn tissue. n = 10. âˆ—p < 0.05 vs. normal rats, #p < 0.05 vs.
  rat models of DNP, and &p < 0.05 vs. DNP model rats treated with BHF177. n = 10
  rats per group.'
article_title: BHF177 Suppresses Diabetic Neuropathic Pain by Blocking PKC/CaMKII/ERK1/2/CREB
  Signaling Pathway through Activating GABAB Receptor.
citation: Boyu Liu, et al. Oxid Med Cell Longev. 2022;2022:4661519.
year: '2022'

doi: 10.1155/2022/4661519
journal_title: Oxidative Medicine and Cellular Longevity
journal_nlm_ta: Oxid Med Cell Longev
publisher_name: Hindawi

keywords:
---
